Status:
UNKNOWN
Dislocation Precautions
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Arthroplasty, Hip Replacement
Arthroplasties, Hip Replacement
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is looking at the impact of giving patients precautions, or restrictions for movement, when undergoing a total hip replacement. Have of the participants will receive precautions, while the ...
Detailed Description
Patients undergoing hip replacements are often told by health care providers to avoid specific positions and activities to decrease the risk of their hip dislocating following their surgery. This, how...
Eligibility Criteria
Inclusion
- Receiving a primary total hip arthroplasty (THA) due to osteoarthritis or osteonecrosis
- Over 18
- Willing and able to sign consent
Exclusion
- Receiving a lateral approach hip arthroplasty
- Cannot make follow up visits
Key Trial Info
Start Date :
June 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 21 2023
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT03806114
Start Date
June 21 2019
End Date
December 21 2023
Last Update
August 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6